ASH2020: New Studies Showcase Potential of CAR-T Therapy to Treat More Cancers
Results of two promising cell therapy studies involving Kite Pharma’s Yescarta were discussed at the 62nd American Society of Hematology Annual Meeting & Exposition (ASH 2020). A study that used …
Read More